Alterity Therapeutics Limited | PRAN - Operating Profit


Alterity Therapeutics Limited reported AUD-7.77M in Operating Profit for its fiscal semester ending in June of 2023.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Arca Biopharma USD -34.43M 326K Dec/2025
aTyr Pharma USD 24.47M 51.21M Dec/2025
Bio Path USD -488K 4.07M Sep/2025
Brainstorm Cell Therapeutics USD -2.05M 526K Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cara Therapeutics USD -2.39M 3.49M Mar/2025
CSL USD 2.64B 1.97B Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Immunic USD -25.73M 2.91M Sep/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Insmed USD -249.71M 11.64M Dec/2025
Minerva Neurosciences USD -21.85M 17.48M Dec/2024
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
TherapeuticsMD USD -1.18M 40K Jun/2024